Literature DB >> 16683859

Monoamine depletion studies: implications for antidepressant discontinuation syndrome.

Pedro L Delgado1.   

Abstract

The likelihood of a connection between serotonin reuptake inhibitor (SRI) discontinuation and an acute reduction in synaptic serotonin (5-HT) has ignited interest in the similarities between SRI discontinuation syndrome and the symptoms observed after acute tryptophan depletion, which reduces synaptic 5-HT levels. An open question is whether these 2 phenomena have shared characteristics because of a similar underlying mechanism. The evidence in support of a similar underlying mechanism includes the observation that comparable proportions of SRI-treated patients experience depressive symptoms following tryptophan depletion and SRI discontinuation. Furthermore, the proportion of people who have emotional changes with rapid antidepressant discontinuation may be parallel to the proportion of people who experience those changes with rapid tryptophan depletion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16683859

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  25 in total

1.  Uncontrolled self-medication with venlafaxine in a patient with major depressive disorder.

Authors:  Ji-Hye Song; Bum-Hee Yu; Dongsoo Lee; Se Chang Yoon; Hong Jin Jeon
Journal:  Psychiatry Investig       Date:  2010-12-31       Impact factor: 2.505

2.  Increase the dose or give it a few more weeks.

Authors:  Colleen A Blanchfield
Journal:  Psychiatry (Edgmont)       Date:  2007-03

3.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

4.  Glucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibition.

Authors:  Melanie Y Vincent; Lauren Jacobson
Journal:  Eur J Neurosci       Date:  2014-03-29       Impact factor: 3.386

5.  Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Authors:  Robin L Carhart-Harris; David J Nutt; Marcus R Munafo; David M Christmas; Sue J Wilson
Journal:  Psychopharmacology (Berl)       Date:  2009-07-08       Impact factor: 4.530

6.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

7.  Recognition and management of antidepressant discontinuation syndrome.

Authors:  Venkat Bhat; Sidney H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2017-06       Impact factor: 6.186

8.  Dorsal raphé nucleus glucocorticoid receptors inhibit tph2 gene expression in male C57BL/6J mice.

Authors:  Melanie Y Vincent; Nina C Donner; David G Smith; Christopher A Lowry; Lauren Jacobson
Journal:  Neurosci Lett       Date:  2017-11-22       Impact factor: 3.046

Review 9.  Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale.

Authors:  Jacob P R Jacobsen; Andrew D Krystal; K Ranga R Krishnan; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2016-09-28       Impact factor: 14.819

10.  Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.

Authors:  Willem Heydendael; Lauren Jacobson
Journal:  Brain Res       Date:  2009-07-03       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.